Both MovAiD and Keep Control rely on objective movement measurement, which is the core commercial capability GAIT UP SA brings to research consortia.
GAIT UP SA
Swiss SME providing wearable motion and gait analysis technology for rehabilitation, assistive devices, and movement disorder research.
Their core work
GAIT UP SA is a Swiss technology SME based in Lausanne that develops wearable inertial sensor systems for capturing and analyzing human movement and gait patterns. Their technology enables objective, quantitative assessment of walking, balance, and motor function using body-worn sensors — replacing subjective clinical observation with real data. In EU research projects, they function as a specialist technology provider, contributing their sensor hardware and motion analysis software to consortia working on movement-assistive devices and neurological disorder diagnosis. Their work sits at the intersection of biomechanics, medical technology, and wearable electronics.
What they specialise in
MovAiD (2015–2018) focused on manufacturing personalized kineto-dynamics parts and movement assisting devices specifically for workers.
Keep Control (2017–2021) was a Marie Curie training network targeting specific diagnosis and treatment of age-related conditions, where gait analysis is a primary diagnostic tool.
The kineto-dynamics focus of MovAiD suggests a role in capturing individual movement data to inform the manufacturing of personalized orthotic or assistive components.
How they've shifted over time
No keyword metadata is available for either period, so evolution must be inferred from project scope and timing. In the earlier period (MovAiD, 2015–2018), GAIT UP SA engaged with manufacturing-adjacent research — specifically, generating movement data to drive the production of personalized kineto-dynamics parts for workers, an occupational health and industrial rehabilitation angle. The later project (Keep Control, 2017–2021) shifted toward a clinical and academic training context, with focus on age-related neurological and mobility conditions, placing their technology closer to medical diagnosis and geriatric care. The overall trajectory moves from industrial/manufacturing applications toward clinical and aging-population healthcare, which is a broader and faster-growing market.
GAIT UP SA appears to be moving from industrial rehabilitation applications toward clinical diagnosis of movement disorders in older adults — a direction aligned with growing European demand for digital health tools in aging populations.
How they like to work
GAIT UP SA has participated exclusively as a non-coordinator partner across both projects, indicating they prefer — or are positioned as — specialist contributors rather than project leaders. Despite only two projects, they have accumulated 23 unique consortium partners across 10 countries, suggesting they join large, multi-partner consortia rather than small bilateral collaborations. This profile is consistent with a technology SME that plugs its sensor platform into research teams as a measurement and data capture component, rather than driving the research agenda itself.
With 23 unique consortium partners across 10 countries from just 2 projects, GAIT UP SA has built a disproportionately wide network for its size — reflecting participation in large EU research consortia rather than narrow bilateral collaborations. Their network spans industrial and academic partners across multiple European countries, consistent with RIA and MSCA-ITN funding structures.
What sets them apart
As a Lausanne-based SME, GAIT UP SA operates within one of Europe's densest medtech and precision engineering ecosystems, with proximity to EPFL and a strong regional base in wearable health technology. Unlike large medical device companies, they bring focused sensor-platform expertise at a scale and cost accessible to research consortia and mid-size industry partners. For a consortium builder, they represent a practical bridge between biomechanics research and industrial or clinical application — a role that few SMEs can credibly fill across both manufacturing and healthcare contexts.
Highlights from their portfolio
- Keep ControlThe only project with confirmed EC funding (EUR 265,227), and participation in a prestigious Marie Curie Initial Training Network signals recognition of GAIT UP SA's measurement technology as essential to cutting-edge neurological and aging research.
- MovAiDAn early RIA project linking gait/motion sensing directly to the manufacturing of personalized assistive devices for workers — an unusual combination of biomechanics data and industrial production that demonstrates cross-sector applicability.